Key facts
- It has raised $750K; the latest was Early Stage VC ($750K) in Dec 2024.
- Notable investors include Rockies Venture Club, AgeTech Collaborative from AARP, Atlanta Tech Village.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for MyUTI
- ·The full record, as it builds
Funding rounds
No funding rounds for MyUTI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MyUTI
Operator of a digital wellness platform designed to reduce antibiotic resistance. The company's platform provides access to a telehealth specialty network to get immediate care for urinary tract infections as well as on-demand access to testing and clinical experts, it offers comprehensive diagnostic testing and harnesses the power of machine learning to create advanced clinical support tools and not only improves patient outcomes but also sets a new standard in the management of pelvic health issues, enabling patients to overcome disruptive, painful, and frustrating caused by bacteria entering the urinary tract.
- Sector
- Healthcare
- HQ
- Parker, CO, United States
- Founded
- 2020
- Employees
- 5
- Website
- myuti.com/
- Ownership
- Privately Held (backing)
MyUTI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MyUTI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MyUTI in its N-PORT filings yet. We sweep new filings monthly.